Shares in FTSE 100 giant AstraZeneca (LSE:AZN) are up 22% in three months, but is it a good time to buy? The post Up 22% in 3 months! Should investors consider buying shares in this FTSE 100 pharma ...
"I just liked working with them so much that I joined them," Chen told BioWorld. Today, Chen is co-CEO of WuXi AppTec. The company, which started with a laboratory of 7,000 square feet, has grown into ...
Complex is relaunching Verzuz at ComplexCon 2025 through an exclusive partnership, with Cash Money Records and No Limit ...
Lignins—the complex molecules that make plants sturdy and allow them to grow tall—are not as random as once thought. A new ...
Who Decides War: Founded by Ev Bravado and Tela D’Amore, WDW has been a defining element of New York City street style and a ...
In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of ...
More than that, however, Gege also showed his own brilliance by introducing new techniques to the story. Jujutsu Kaisen ...
McMaster University has synthesized radiolabeled-drug conjugates comprising a glutamate carboxypeptidase 2 (FOLH1; NAALAD1; PSMA)-targeting moiety covalently linked to a DNA intercalating agent ...